Zoloft alternatives if not eligible

Finding quality mental healthcare shouldn’t feel like navigating a minefield. Yet in 2025, the telehealth industry looks dramatically different than it did just a few years ago—some platforms have shuttered, others face legal scrutiny, and new regulations are reshaping how care is delivered online.

If you’re seeking treatment for ADHD, anxiety, depression, or related conditions through telehealth, you’re likely wondering: Which platforms are still operating? Who can actually prescribe the medications I need? And how do I find trustworthy care that won’t break the bank?

This comprehensive guide breaks down the current state of online mental health services, comparing major providers on availability, prescribing policies, pricing, and quality of care—so you can make an informed decision about your treatment.

The Telehealth Shake-Up: What Changed and Why It Matters

The explosive growth of mental health telehealth during the COVID-19 pandemic created both opportunities and problems. By 2022, regulatory scrutiny intensified around platforms that seemed to prioritize convenience over clinical appropriateness—particularly regarding controlled substances like Adderall and Xanax.

Two major developments reshaped the landscape:

Done Global’s Legal Crisis: In June 2024, federal prosecutors indicted Done’s CEO and clinical president for allegedly operating a ‘pill mill’ that distributed over 40 million Adderall pills inappropriately. This marked the first criminal prosecution of telehealth executives for controlled substance violations, effectively shutting down Done’s operations.

Cerebral’s Policy Reversal: Once a leader in ADHD telehealth, Cerebral stopped prescribing all new stimulant medications in May 2022 after investigations revealed internal pressure on clinicians to meet prescription quotas. The company paid $3.6 million in settlements by late 2024 and fundamentally restructured its approach to controlled medications.

These events didn’t just affect two companies—they triggered industry-wide policy changes. Most direct-to-consumer platforms now restrict or completely prohibit prescribing Schedule II stimulants, benzodiazepines, and certain sleep medications via telehealth.

What this means for you: Finding legitimate online ADHD treatment or anxiety medication has become more challenging. However, quality providers still exist—you just need to know where to look and what to expect.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Comparing Top Telehealth Providers: Who Offers What?

The table below provides a comprehensive comparison of major mental health telehealth platforms currently operating in 2025, including their prescribing capabilities, geographic availability, and pricing structures.

Current Provider Landscape (2025)

Key Takeaway: If you need ADHD stimulant medications or benzodiazepines, Talkiatry is currently the most comprehensive option among mainstream telehealth providers. However, insurance-based psychiatry platforms often involve longer wait times and less flexibility than cash-pay services.

Understanding Medication Prescribing Policies in 2025

One of the biggest sources of confusion—and frustration—for telehealth patients is understanding what medications different platforms will and won’t prescribe. Here’s what you need to know:

ADHD Stimulants (Adderall, Ritalin, Vyvanse)

Current Reality: Most direct-to-consumer telehealth platforms do not prescribe Schedule II stimulants for ADHD.

Why the change? The combination of regulatory pressure, DEA scrutiny, and high-profile legal cases led most platforms to adopt conservative policies. While the Ryan Haight Act waiver (allowing tele-prescribing of controlled substances) has been extended through the end of 2025, uncertainty about future regulations has made companies cautious.

Your options if you need ADHD medication:

• Talkiatry and similar insurance-based psychiatric platforms still prescribe stimulants when clinically appropriate, following comprehensive evaluations
• Klarity Health offers ADHD evaluation and treatment, including medication management, with board-certified providers who take both insurance and cash pay
• Traditional in-person psychiatrists remain an option, though availability varies by location

What about Cerebral? While Cerebral continues serving existing ADHD patients (those established before May 2022), they no longer accept new patients seeking stimulant prescriptions. They focus on non-controlled alternatives like Strattera or Wellbutrin for ADHD management.

Anti-Anxiety Medications (Benzodiazepines)

The situation: Nearly all telehealth platforms explicitly prohibit prescribing benzodiazepines like Xanax (alprazolam), Ativan (lorazepam), or Klonopin (clonazepam).

Platforms that won’t prescribe benzos:

• Brightside (policy: ‘non-addictive medications only’)
• Cerebral (conservative approach after 2022)
• PlushCare, Teladoc, Amwell (company-wide policies)
• Hims/Hers (no controlled substances)

Alternative approaches: These platforms typically offer:

• SSRIs or SNRIs for long-term anxiety management
• Buspirone (non-controlled anxiety medication)
• Hydroxyzine (antihistamine with anti-anxiety properties)
• Therapy and cognitive-behavioral strategies

When benzos are appropriate: Talkiatry and specialty psychiatric services may prescribe benzodiazepines for specific clinical situations (panic disorder, acute anxiety) after thorough evaluation, but even these providers use them conservatively due to dependency risks.

Sleep Medications

Controlled sleep aids like Ambien (zolpidem), Lunesta (eszopiclone), and similar ‘Z-drugs’ are largely unavailable through telehealth platforms.

Why? These Schedule IV medications carry abuse potential and require careful monitoring. Telehealth platforms generally lack the infrastructure for the frequent follow-ups these medications demand.

Alternatives offered:

• Trazodone (antidepressant used off-label for sleep)
• Melatonin and melatonin agonists (Rozerem)
• Antihistamines (doxylamine, diphenhydramine)
• Cognitive behavioral therapy for insomnia (CBT-I)

Weight Loss Medications: A New Frontier

Here’s where the landscape gets interesting. While traditional controlled weight-loss medications (like phentermine) remain restricted, the emergence of GLP-1 medications (Wegovy, Ozempic, Mounjaro) has opened new opportunities in telehealth.

Hims & Hers launched comprehensive GLP-1 weight loss programs in 2023, capitalizing on the telehealth-friendly nature of these non-controlled medications. PlushCare also prescribes GLP-1s for obesity with comorbidities.

Important caveat: The FDA issued warning letters in 2025 to several telehealth platforms regarding compounded semaglutide, so verify that any provider uses FDA-approved formulations.

What Patients Are Really Saying: Quality and Experience

Beyond prescribing policies and pricing, what matters most is whether these platforms deliver quality care. Here’s what real patient experiences reveal:

The Good

Brightside receives generally positive reviews for depression and anxiety treatment, with patients appreciating the structured approach and responsive providers. The platform’s focus on evidence-based, non-controlled medications appeals to those seeking safer long-term solutions.

Talkiatry earns praise for comprehensive psychiatric evaluations and access to experienced psychiatrists. Patients value the legitimacy of working with board-certified MDs who can handle complex cases.

Hims/Hers gets high marks for transparency, ease of use, and straightforward pricing—though services are more appropriate for mild conditions rather than complex mental health needs.

The Challenges

Cerebral faces ongoing complaints about:

• Provider turnover (difficulty maintaining continuity of care)
• Customer service responsiveness
• Subscription cancellation difficulties
• The abrupt policy changes that left ADHD patients scrambling for alternatives

Done (before its shutdown) had numerous complaints about:

• Rushed 10-minute evaluations
• Difficulty reaching prescribers between appointments
• Sudden service disruptions when pharmacies refused to fill prescriptions

General telehealth platforms (Teladoc, MDLive, Amwell) often frustrate mental health patients because:

• Their generalist approach doesn’t suit complex psychiatric conditions
• The rotating provider model prevents relationship-building
• Restrictive medication policies leave patients feeling undertreated

The Subscription Model Problem

Several platforms use monthly subscription pricing that bundles services together. While this seems convenient, patients frequently report:

Flexibility issues: Paying monthly fees even during months without appointments

Hidden costs: Base subscription fees don’t always include medication costs, therapy sessions, or follow-ups—leading to surprise bills

Cancellation difficulties: Some platforms make it challenging to pause or cancel subscriptions

Better alternatives: Services offering à la carte pricing (pay only for what you use) often provide better value, especially for patients with stable conditions requiring only occasional check-ins.

Availability in Key States

If you’re located in California, Texas, Florida, New York, Pennsylvania, or Illinois—six of the most populous states—you’re in luck. All currently active major telehealth providers serve these states:

Available in all six states:

• Cerebral (limited services)
• Brightside
• Talkiatry
• PlushCare
• MDLive
• Teladoc
• Amwell
• Hims/Hers
• Klarity Health

Not available: Done (inactive nationwide), Ahead (closed)

State licensing matters: Providers must be licensed in your state to treat you. Most platforms have either nationwide coverage or are rapidly expanding. However, some specialty services (like Talkiatry) operate in only 43 states, so verify availability for your specific location.

Pricing Transparency: What You’ll Actually Pay

Healthcare pricing shouldn’t require a detective’s investigation. Here’s what you can realistically expect to pay at major platforms:

Subscription-Based Services

Cerebral:

• Medication management only: $99/month
• Therapy + medication: $365/month
• Note: Limited insurance acceptance means most pay out-of-pocket

Brightside:

• Medication management: $95/month
• Therapy + medication: $349/month
• Insurance may cover portions depending on plan

Hims/Hers:

• Mental health medication plan: $85/month
• Individual therapy sessions: $99 each
• No insurance accepted, but HSA/FSA eligible

Insurance-Based Services

Talkiatry:

• With insurance: Typically $25-50 copay per visit
• Without insurance: $250-300 initial evaluation, $150-175 follow-ups

PlushCare:

• Membership: $19.99/month
• Per visit: $129 (often covered by insurance)

Teladoc/MDLive/Amwell:

• Often $0-50 with insurance (many employers provide coverage)
• Without insurance: $75-120 per visit depending on service type

Alternative Model: Cash-Pay with Transparency

Klarity Health offers straightforward pricing:

• Initial psychiatric evaluation: Around $149
• Follow-up visits: $59
• Medication refill requests: $25
• Accepts both insurance and cash payment

This à la carte approach often costs less overall than monthly subscriptions if you have a stable condition requiring only periodic check-ins—and you won’t pay for months when you don’t need care.

How Klarity Health Fits Into the Landscape

Given the challenges outlined above, where does Klarity Health position itself?

Addressing the Trust Gap

After the Done and Cerebral controversies, patients rightfully question whether online providers prioritize convenience over quality. Klarity Health bridges this gap by:

Providing legitimate psychiatric care: Board-certified providers who follow established clinical guidelines—not rushed evaluations designed to maximize prescriptions

Offering necessary medications responsibly: Unlike platforms that categorically refuse controlled substances, Klarity prescribers can provide ADHD stimulants, appropriate anxiety medications, or sleep aids when clinically warranted, following proper evaluation protocols

Maintaining reasonable access: You shouldn’t wait weeks for an appointment, but you also shouldn’t get prescribed serious medications after a 10-minute chat. Klarity balances accessibility with thoroughness.

Filling Service Gaps

Many competitors excel in one area but fall short in others. Klarity aims for comprehensive care:

Beyond basic mental health: While general telehealth platforms (Teladoc, Amwell) treat simple conditions, they refer out anything complex. Klarity handles ADHD, PTSD, OCD, insomnia, and other conditions that require specialty psychiatric expertise.

Broader than single-condition services: Unlike Brightside (which doesn’t treat ADHD) or former ADHD-only services (Done, Ahead), Klarity addresses multiple conditions—including emerging areas like PMDD, binge eating disorder, and even metabolic health concerns.

More flexible than insurance models: While Talkiatry’s insurance-based approach suits some patients, others face long waits, limited appointment times, or high deductibles. Klarity’s dual model (accepting both insurance and cash) provides options.

Transparent, Fair Pricing

The subscription fatigue is real. Patients appreciate knowing exactly what they’ll pay without surprise charges, forced monthly fees, or complex insurance calculations. Klarity’s straightforward pricing structure provides predictability—especially valuable for those comparing costs across platforms or managing healthcare budgets.

Continuous, Personalized Care

Provider turnover plagued Cerebral. Rotating doctors frustrate patients on general telehealth platforms. Building a therapeutic relationship matters for mental healthcare—seeing the same provider who knows your history, understands your responses to treatment, and can adjust care thoughtfully over time produces better outcomes.

What to Consider When Choosing a Telehealth Provider

As you evaluate options, consider these factors:

1. Condition Complexity

• Simple depression/anxiety with no medication needs? Brightside, Hims/Hers, or general platforms may suffice
• ADHD requiring stimulant medication? Talkiatry, Klarity Health, or in-person psychiatry
• Multiple conditions or previous treatment failures? Specialty psychiatric services, not generalists

2. Medication Requirements

• Need controlled substances? Verify the platform’s prescribing policy upfront—don’t waste time and money on evaluations with providers who can’t prescribe what you need
• Prefer non-controlled alternatives? More options available across platforms

3. Insurance vs. Cash Pay

• Good insurance with mental health coverage? Talkiatry, PlushCare, or traditional platforms maximize benefits
• High deductible, limited mental health coverage, or no insurance? Cash-pay services with transparent pricing (Klarity, Hims/Hers) may cost less overall
• Want flexibility? Services accepting both provide options

4. Appointment Availability

• Need care quickly? Cash-pay platforms typically offer appointments within days
• Can wait 2-3 weeks? Insurance-based services often have longer initial waits but may cost less

5. Continuity of Care

• Long-term mental health management? Prioritize platforms offering consistent provider relationships
• One-time or occasional needs? Rotating provider models work fine

Looking Ahead: The Future of Mental Health Telehealth

Several trends will shape telehealth in 2026 and beyond:

Regulatory Evolution

The Ryan Haight Act waiver allowing controlled substance prescribing via telehealth expires at the end of 2025. Congress and federal agencies will determine whether to extend, modify, or end these flexibilities. Potential outcomes:

Full extension: Maintains current telehealth capabilitiesModified approach: May require initial in-person visits or periodic in-person check-insReversion to pre-COVID rules: Would require in-person examination before any controlled substance prescription

Smart providers are preparing by developing hybrid models, establishing partnerships with local clinics, or focusing on conditions treatable without controlled medications.

Consolidation and Integration

The industry shake-out continues. Expect more:

• Acquisitions of smaller startups by large healthcare companies
• Integration of telehealth into traditional healthcare systems
• Partnerships between online and in-person providers

For patients, this means potentially better coordination of care but also less competition and possibly higher prices from consolidated players.

Specialty Expansion

Mental health telehealth is expanding beyond anxiety and depression into:

• Perinatal mental health: PMDD, postpartum depression, pregnancy-related anxiety
• Ketamine therapy: For treatment-resistant depression
• Adolescent psychiatry: Talkiatry’s 2025 expansion into youth services signals growing recognition of this need
• Integrated metabolic-mental health: Addressing connections between mental health, weight, hormones, and overall wellness

Quality Standards Tightening

Expect increased emphasis on:

• Outcome tracking: Measuring whether patients actually improve
• Accreditation: Third-party verification of clinical quality
• Transparency: Clear disclosure of clinician qualifications, prescribing practices, and success rates

Savvy patients should look for these quality indicators when choosing providers.

Making Your Decision: Next Steps

The telehealth mental health landscape in 2025 offers both more options and more complexity than ever before. Here’s your action plan:

Step 1: Clarify Your Needs

• What conditions need treatment?
• What medications (if any) have helped in the past?
• What’s your budget and insurance situation?
• How quickly do you need care?

Step 2: Shortlist Appropriate Providers

Based on your needs:

• ADHD with stimulant medication: Talkiatry, Klarity Health, or pursue in-person psychiatry
• Depression/anxiety without controlled substances: Brightside, Hims/Hers, general platforms
• Complex or multiple conditions: Specialty psychiatric services (Talkiatry, Klarity)
• Budget-conscious with insurance: Talkiatry, PlushCare, or employer-provided services
• Want flexibility and transparency: Klarity Health or other à la carte services

Step 3: Verify Specifics

Before committing:

• Confirm the provider serves your state
• Understand exactly what you’ll pay (including medications)
• Check prescribing policies for your needed medications
• Read recent patient reviews
• Clarify cancellation or refund policies

Step 4: Start Care

Most platforms offer:

• Free initial consultations or assessments
• Clear onboarding processes
• Quick appointment scheduling

If something feels rushed, impersonal, or questionable—trust your instincts. Quality mental healthcare should feel thorough, collaborative, and focused on your specific needs.

The Bottom Line

The mental health telehealth revolution has matured from its Wild West phase into a more regulated, quality-focused industry. While some providers fell by the wayside and others restricted services, legitimate options remain for patients seeking convenient, effective care.

The key is matching your specific needs with a provider’s strengths:

• Need comprehensive psychiatric services including controlled medications? Look for specialty platforms with full prescribing capabilities
• Prefer a conservative, subscription-based approach for common conditions? Consider established services like Brightside
• Want the legitimacy of insurance-based care with board-certified psychiatrists? Talkiatry offers this
• Value transparent pricing, provider continuity, and comprehensive condition coverage? Klarity Health bridges many gaps left by competitors

Remember: Online mental healthcare is legitimate healthcare. You deserve the same quality, safety, and personalized attention you’d expect from in-person treatment—just delivered more conveniently. Don’t settle for rushed evaluations, restricted treatment options, or opaque pricing. The right provider should make you feel heard, offer evidence-based treatment options, and support your mental health journey with consistency and care.

Ready to explore your options with Klarity Health? Schedule a consultation to discuss your specific needs with a board-certified provider who can offer comprehensive evaluation and treatment—including medications when clinically appropriate—with transparent pricing and flexible payment options. Because your mental health is too important for one-size-fits-all solutions.

Key References

1. Associated Press. ‘Top executives of ADHD telehealth company Done indicted for $100 million fraud.’ June 14, 2024. apnews.com

2. TechTarget Healthcare IT News. ‘Pushing ADHD telehealth prescriptions costs Cerebral millions.’ November 6, 2024. techtarget.com

3. TIME Magazine. ‘Why Online Therapy Startups Like Cerebral and Done Are Falling Short.’ November 1, 2022. time.com

4. Brightside Health. ‘What medications do we prescribe?’ Official FAQ. 2025. brightside.com

5. FinvsFin. ‘Hims Anxiety Reviews: Cost & Mental Health Services.’ December 9, 2025. finvsfin.com

📅 Research Currency Statement: Information verified as of January 4, 2026. Provider statuses, policies, and pricing current as of this date based on official company sources, recent news reports, and industry analyses.

Source:

• https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions#:~:text=Cerebral%20provides%20telehealth%20consultations%20for,from%20tiered%20monthly%20subscription%20plans
• https://finvsfin.com/hims-anxiety-reviews/#:~:text=Out%20of%20pocket%2C%20Hims%20will,99%20for%20each%20counseling%20session
• https://apnews.com/article/498cb907623565ee680b33b1367efb84#:~:text=Top%20executives%20of%20the%20California,executives%20of%20defrauding%20taxpayers%2C%20exacerbating
• https://time.com/6225361/telehealth-startups-cerebral-done-ahead/#:~:text=Halcyon%20Health%20and%20ADHD,Ahead%20shut%20down%20this%20year
• https://www.techtarget.com/virtualhealthcare/news/366615298/Pushing-ADHD-telehealth-prescriptions-costs-Cerebral-millions#:~:text=Embattled%20telemental%20healthcare%20provider%20Cerebral,unauthorized%20distribution%20of%20controlled%20substances
• https://apnews.com/article/9c08db3481dcfd67c433fad1ae07d941#:~:text=The%20FDA%20has%20launched%20its,originals%2C%20which%20the%20FDA%20disputes
• https://www.teladochealth.com/info/prescription-policy#:~:text=pressure%20medication,well%20as%20Teladoc%20Health%20policy
• https://www.brightside.com/faqs/what-medications-do-we-prescribe/#:~:text=Note%3A%20Brightside%20does%20not%20prescribe,controlled%20substance%20in%20some%20states
• https://time.com/6225361/telehealth-startups-cerebral-done-ahead/#:~:text=substance%20prescriptions%20from%20Cerebral%20and,substance%20medications
• https://h-o-m-e.org/does-cerebral-prescribe-xanax/#:~:text=Cerebral%20takes%20a%20conservative%20approach,such%20as%20Xanax%20or%20Ativan